Byron Wilkes, MD
Ophthalmology · Pine Bluff, ARNPI 1710101977
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Amgen at 39.5% of the total. Reporting peaked in 2024 at $422 and has fallen 69.1% since, to $130 in 2025.
Across 56 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$489
- AbbVie$256
- Alcon$169
- Bausch & Lomb Americas Inc.$79
- Sun Pharmaceutical Industries Inc.$44
- Mallinckrodt Hospital Products Inc.$44
- plus $158 from 7 others
Across 2 payments — averaging $28,558 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$57K
What the payments were for
- Food & beverage$1,238100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 20 | $489 |
| AbbVie(2 entities) | 12 | $256 |
| Alcon | 6 | $169 |
| Bausch & Lomb Americas Inc. | 4 | $79 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| Omeros Corporation | 3 | $41 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Aerie Pharmaceuticals, Inc. | 1 | $18 |
| Eyepoint US, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| Glaukos Corporation | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$121
How this compares
$1,238 in reported general payments places this provider in the 65th percentile of 125 ophthalmology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 807 | $8,494 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 539 | $1,643 |
| Prednisolone Acetate | 55 | $1,542 |
| Bacitracin | 14 | $1,189 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 47 | $535 |
| Doxycycline Hyclate | 18 | $481 |
| Tramadol Hcl | 34 | $67 |
| Cephalexin | 13 | $50 |
| Ondansetron OdtOndansetron | 14 | $48 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Pine Bluff
- Mike McFarlandPine Bluff$63K
- James HoffmannPine Bluff$4K
- Evan NewboltPine Bluff$3K
- Daniel SinesRogers$81K
- Jennifer DoyleLittle Rock$38K
- James LinderMarion$18K
- Matthew MargolisJonesboro$17K
- Thomas StankJonesboro$16K
- Andrew PerinNorth Little Rock$4K
- Jeffrey HoltHot Springs$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.